Mark Kotter
Founder • Bit Bio
Mark is a doctor, scientist, and serial entrepreneur. As a neurosurgeon, he treats patients with spinal cord injury. Mark is best known for discovering the importance of macrophages for brain regeneration, which led to the first regenerative medicine trial for degenerative cervical myelopathy, and for developing opti-ox, a gene targeting approach that enables faithful execution of genetic information in cells.
Also speaking
Elsa Abranches
Senior Director – Head of Cell Therapy Bioprocess Development and Manufacturing • AstraZeneca
20 May 2022
Event Info
2022 Spotlight Roundtables
Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.
8 August 2022
